Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Cancer Prev ; 27(4): 239-246, 2022 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-36713940

RESUMEN

Since ancient times, honey has been used in traditional medicine owing to its pharmacological effects. It possesses anticancer properties. However, the therapeutic implications of Sangju honey in cancer remains unknown. Therefore, we aimed to demonstrate the potential anticancer effects of Sangju honey on human oral squamous cell carcinoma (OSCC), particularly focusing on epithelial-mesenchymal transition (EMT) and apoptotic and mitogen-activated protein kinase (MAPK) signaling pathways. Ca9-22 and YD-10B human OSCC cells were treated with 0.25% or 0.5% Sangju honey, and the cell viability was examined using the Cell Counting Kit-8 assay. Cell morphology studies were conducted to observe morphological changes, and the wound-healing assay was performed to evaluate the proliferation of honey-treated OSCC cells. Western blot analysis was conducted to investigate protein expression related to EMT and apoptotic and MAPK signaling pathways. Sangju honey reduced cell viability, induced morphological changes, and significantly suppressed the proliferation and migration of Ca9-22 and YD-10B cells. The expression of E-cadherin and N-cadherin was increased and decreased, respectively, in both OSCC cell lines. Moreover, Sangju honey stimulated apoptosis by increasing the expression of p21, p53, cleaved caspase 3, and caspase 9. Furthermore, it downregulated the expression of phospho (p)-extracellular signal-regulated kinases 1 and 2, p-c-Jun amino-terminal kinase, and p-p38 in Ca9-22 and YD-10B cells. Sangju honey inhibits Ca9-22 and YD-10B cell proliferation by regulating EMT, inducing apoptosis, and suppressing the MAPK signaling pathway. Thus, it is a potential anticancer agent for human OSCC.

2.
Opt Express ; 16(7): 4866-71, 2008 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-18542585

RESUMEN

We have developed a 5-W 756-nm injection-locked Ti:sapphire laser and frequency-doubled it in an external enhancement cavity for the generation of watt-level 378-nm single-frequency radiation, which is essential for isotope-selective optical pumping of thallium atoms. With a lithium triborate (LBO) crystal in the enhancement cavity, 1.1 W at 378 nm was coupled out from the cavity. Such results are to our knowledge the highest powers of continuous-wave single-frequency radiation generated from a Ti:sapphire laser and its frequency doubling.


Asunto(s)
Óxido de Aluminio , Diseño Asistido por Computadora , Rayos Láser , Modelos Teóricos , Titanio , Simulación por Computador , Diseño de Equipo , Análisis de Falla de Equipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA